RecruitingPhase 4NCT07089251

The Perioperative Outcome of Epinephrine Infusion and Tranexamic Acid in Knee Arthroplasty Surgery


Sponsor

King Abdullah International Medical Research Center

Enrollment

80 participants

Start Date

Jul 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this clinical trial is to evaluate the effect of administering low-dose epinephrine and tranexamic acid on perioperative blood loss, thromboembolic complications, and hospitalization duration in patients undergoing knee joint arthroplasty. Also aim to evaluate the effect of administering low-dose epinephrine and tranexamic acid on perioperative thromboembolic complications, and hospitalization duration


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Tranexamic Acid (TXA) treatment and a drug called low-dose epinephrine and tranexamic acid for people with epinephrine, knee arthritis, osteoarthritis, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGlow-dose epinephrine and tranexamic acid

low-dose epinephrine and tranexamic acid

DRUGTranexamic Acid (TXA) treatment

Tranexamic Acid


Locations(1)

King Abdulaziz Medical City, Ministry of National Guard - Health Affairs

Riyadh, Riyadh Region, Saudi Arabia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07089251


Related Trials